Corcept Therapeutics Incorporated (CORT)

NASDAQ

$87.30

-$0.69 (0.78%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$87.11$89.00

Open $88.74

52 Week Range

$49.00$117.33

Previous Close $87.99

Market Cap9.18B

Volume799.15K

Avg Volume850.66K

P/E (TTM)85.94

EPS (TTM)$1.02

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$140.00

Based on 3 analysts (last year)

High Target

$140.00

Low Target

$140.00

Potential upside of 60.37%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$140.00

3 analysts

All Time

$69.86

14 analysts

Analyst Consensus

Current Consensus

Buy

Based on 24 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

A-

(Score: 4)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows5/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity4/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits5/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity4/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share1/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Sep 10, 2025	Unknown	Canaccord Genuity	$140.00	$71.62	+95.48%
May 6, 2025	Joon Lee	Truist Financial	$135.00	$70.74	+90.84%
May 6, 2025	Swayampakula Ramakanth	H.C. Wainwright	$145.00	$73.94	+96.10%
Oct 18, 2024	Swayampakula Ramakanth	H.C. Wainwright	$80.00	$47.17

Recent Analyst Actions


Nov 25, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Oct 20, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Oct 10, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Sep 25, 2025	Maintained	Canaccord Genuity	Buy	Buy
Sep 10, 2025	Maintained	Canaccord Genuity	Buy	Buy

Showing 1 to 5 of 134 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$140.00

Based on 3 analysts (last year)

High Target

$140.00

Low Target

$140.00

Potential upside of 60.37%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$140.00

3 analysts

All Time

$69.86

14 analysts

Analyst Consensus

Current Consensus

Buy

Based on 24 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

A-

(Score: 4)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows5/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity4/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits5/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity4/5

P/EPrice to Earnings - Ratio of share price to company's earnings per share1/5

P/BPrice to Book - Ratio comparing market price to company's book value per share1/5

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Sep 10, 2025	Unknown	Canaccord Genuity	$140.00	$71.62	+95.48%
May 6, 2025	Joon Lee	Truist Financial	$135.00	$70.74	+90.84%
May 6, 2025	Swayampakula Ramakanth	H.C. Wainwright	$145.00	$73.94	+96.10%
Oct 18, 2024	Swayampakula Ramakanth	H.C. Wainwright	$80.00	$47.17

Recent Analyst Actions


Nov 25, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Oct 20, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Oct 10, 2025	Maintained	HC Wainwright & Co.	Buy	Buy
Sep 25, 2025	Maintained	Canaccord Genuity	Buy	Buy
Sep 10, 2025	Maintained	Canaccord Genuity	Buy	Buy

Showing 1 to 5 of 134 entries